2017
DOI: 10.1016/j.ijpharm.2017.02.024
|View full text |Cite
|
Sign up to set email alerts
|

In situ hybrid nano drug delivery system (IHN-DDS) of antiretroviral drug for simultaneous targeting to multiple viral reservoirs: An in vivo proof of concept

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
21
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
3
2
1

Relationship

1
5

Authors

Journals

citations
Cited by 35 publications
(21 citation statements)
references
References 39 publications
0
21
0
Order By: Relevance
“…Therefore, there is urgent need for improving diagnostic means for early detection and for researching more selective drug release systems with few side effects for treatment. Compared with traditional cancer treatment, the development of nano-targeted drug release systems has led to a new strategy because cellular interaction and communication are often at the nano scale [ 4 , 5 ]. The foremost advantages of employing nano drug delivery systems include specific delivery for targeted action, which can overcome the barrier of drug penetration, and enhancement of the bioavailability and therapeutic performance of antitumor drugs.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, there is urgent need for improving diagnostic means for early detection and for researching more selective drug release systems with few side effects for treatment. Compared with traditional cancer treatment, the development of nano-targeted drug release systems has led to a new strategy because cellular interaction and communication are often at the nano scale [ 4 , 5 ]. The foremost advantages of employing nano drug delivery systems include specific delivery for targeted action, which can overcome the barrier of drug penetration, and enhancement of the bioavailability and therapeutic performance of antitumor drugs.…”
Section: Introductionmentioning
confidence: 99%
“…In contrast, in situ nanotechnology presents a method wherein generation of NPs is achieved by simple addition of a monophasic preconcentrate comprising drug, carrier (polymer/lipid), and stabilizers to an aqueous phase. Our group has reported in situ nanotechnology as a facile method for instantaneous and on‐site generation of NPs to enable point of care application . A distinct advantage of in situ technology is total bypass of the technological hurdles and stability issues associated with conventional NP fabrication methods.…”
Section: Introductionmentioning
confidence: 99%
“…An in situ hybrid nanoparticulate drug delivery system of nevirapine designed for simultaneous targeting of multiple reservoirs in HIV exhibited >90% drug entrapment in a mixture of solid lipid NPs and micelles which was instantaneously generated when the preconcentrate was diluted with isotonic dextrose injection. Following intravenous administration in Sprague Dawley rats, the heterogenous nanosystem revealed high drug accumulation in the RES organs of liver and spleen and also the brain, which represents a remote HIV reservoir …”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations